VTRS
$9.18
Viatris
($.03)
(.33%)
VTRS
Earnings Whisper ®
N/A
3rd Quarter September 2022
Consensus:  $0.82
Revenue:  $4.18 Bil
Monday
Nov 7
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Monday, August 8, 2022

What do you expect when VTRS reports earnings?
Beat
Meet
Miss

Where is VTRS's stock price going from here?
Up
Flat
Down
Stock chart of VTRS
Analysts
Summary of analysts' recommendations for VTRS
Score
Grade
Pivots
Resistance
$9.77
$9.49
$9.35

$9.07

Support
$8.93
$8.65
$8.51
Tweet
Growth
Description
Viatris Inc. is a healthcare company. It provides access to medicines, advance sustainable operations, develop solutions and leverage to connect more people to more products and services through Global Healthcare Gateway(TM). Viatris Inc., formerly known as Mylan NV, is based in PITTSBURGH.